m-Enalapril New Zealand - English - Medsafe (Medicines Safety Authority)

m-enalapril

multichem nz limited - enalapril maleate 20mg;   - tablet - 20 mg - active: enalapril maleate 20mg   excipient: ferrous oxide hypromellose lactose maize starch purified talc stearic acid - all grades of essential hypertension.

ENALAPRIL/HCTZ TABLET Canada - English - Health Canada

enalapril/hctz tablet

frosst a division of merck canada inc - enalapril sodium; hydrochlorothiazide - tablet - 8mg; 25mg - enalapril sodium 8mg; hydrochlorothiazide 25mg - angiotensin-converting enzyme inhibitors

Enalapril Actavis New Zealand - English - Medsafe (Medicines Safety Authority)

enalapril actavis

actavis new zealand limited - enalapril maleate 10mg - tablet - 10 mg - active: enalapril maleate 10mg excipient: iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch pregelatinised maize starch sodium bicarbonate

Enalapril Actavis New Zealand - English - Medsafe (Medicines Safety Authority)

enalapril actavis

actavis new zealand limited - enalapril maleate 20mg - tablet - 20 mg - active: enalapril maleate 20mg excipient: iron oxide red lactose monohydrate magnesium stearate maize starch pregelatinised maize starch sodium bicarbonate

Co-Enalapril EG 20 mg - 12.5 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

co-enalapril eg 20 mg - 12.5 mg tabl.

eg sa-nv - enalapril maleate 20 mg; hydrochlorothiazide 12,5 mg - tablet - 20 mg - 12,5 mg - enalapril maleate 20 mg; hydrochlorothiazide 12.5 mg - enalapril and diuretics

Co-Enalapril Sandoz 20 mg - 12,5 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

co-enalapril sandoz 20 mg - 12,5 mg tabl.

sandoz sa-nv - enalapril maleate 20 mg; hydrochlorothiazide 12,5 mg - tablet - 20 mg - 12,5 mg - enalapril maleate 20 mg; hydrochlorothiazide 12.5 mg - enalapril and diuretics

ENALAPRIL MALEATE tablet United States - English - NLM (National Library of Medicine)

enalapril maleate tablet

teva pharmaceuticals usa, inc. - enalapril maleate (unii: 9o25354epj) (enalaprilat anhydrous - unii:q508q118jm) - enalapril maleate 2.5 mg - enalapril maleate tablets are indicated for the treatment of hypertension. enalapril maleate tablets are effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of enalapril maleate tablets and thiazides are approximately additive. enalapril maleate tablets are indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. in these patients enalapril maleate tablets improve symptoms, increase survival, and decrease the frequency of hospitalization (see clinical pharmacology , heart failure, mortality trials for details and limitations of survival trials). in clinically stable asymptomatic patients with left ventricular dysfunction (ejection fraction ≤ 35 percent), enalapril maleate tablets decrease the rate of development of overt heart failure and decrease the incidence of hospitalization for heart failure (see clinical pharmacology , heart failure, mortality tria